Skip to main content
Clinical Trials/NCT01727050
NCT01727050
Completed
Phase 3

Randomized Prospective Trial of Fibrin Sealant Spray Versus Mechanical Stapling in Laparoscopic Totally Extraperitoneal Hernioplasty

Chinese University of Hong Kong1 site in 1 country129 target enrollmentJune 2007
ConditionsHernia

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Hernia
Sponsor
Chinese University of Hong Kong
Enrollment
129
Locations
1
Primary Endpoint
Incidence of chronic pain
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Laparoscopic totally extraperitoneal hernioplasty (TEP) is one of the treatment options for the repair of primary unilateral inguinal hernia. Previous studies showed that patients underwent TEP have less post-operative pain and earlier return to normal activities. However, chronic pain is still a major issue affecting quality of life after TEP with a reported incidence of 9.2-22.5%. Mechanical stapling is the most commonly used method of mesh fixation to prevent mesh migration but nerve entrapment by staples causing intractable pain had been reported. Recently several clinical trials showed that mesh fixation with fibrin sealant (FS) in TEP resulted in less chronic pain but increased incidence of seroma. A spraying device for application of FS laparoscopically is now available which can achieve mesh fixation by using fewer amounts of FS.

In this study, the investigators aim to compare the effectiveness of using fibrin spray for mesh fixation in reducing chronic pain after TEP. The investigators performed a randomized controlled trial by allocating patients in two study arm in random manner. The treatment group will have the mesh fixed by fibrin sealant spray, whereas the control group will have conventional mechanical staples for fixation. Operative procedures and post-operative management for the 2 groups will be identical. They will be follow-up at 1-month and 6-month after operation to evaluate the operative results and the incidence of chronic pain. Any complications related to the mesh and operation will also be recorded.

Registry
clinicaltrials.gov
Start Date
June 2007
End Date
December 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Anthony Teoh

Honorary Assistant Professor

Chinese University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Consecutive male patients aged between 18 to 70 years with reducible unilateral inguinal hernia undergoing day-case TEP under general anaesthesia will be considered eligible.

Exclusion Criteria

  • Bilateral hernia, recurrent hernia, partially reducible or strangulated hernia, large inguinal-scrotal hernia, previous abdominal incision (including previous contralateral hernia repair), peripheral neuropathy, coagulopathy or taking anticoagulation drugs, end-stage renal failure, cirrhosis, impaired cognitive function and those not consent to study.

Outcomes

Primary Outcomes

Incidence of chronic pain

Time Frame: 6 months

Secondary Outcomes

  • Morbidities(30 day)
  • Recurrence rate(6 month)
  • Severity of acute pain(1 week)
  • Quality of life assessment(6 months)

Study Sites (1)

Loading locations...

Similar Trials